Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07293689 · ClinicalTrials.gov registry record

PREcision MEDicine In Achalasia (PREMEDIA) - Cohort

A clinical trial, sponsored by Northwestern University.

Recruiting
Registry status
200
Enrollment target

NCT07293689: Recruiting study, sponsored by Northwestern University.

NCT07293689 is a clinical trial that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07293689 is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
200 participants
Enrollment target

Study Summary

The goal of this observational study is to learn about how the doctor decides how long to cut t the esophageal muscle during Per-Oral Endoscopic Myotomy (POEM) in patients with difficulty swallowing due to certain conditions. The main question it aims to answer is: does pre-POEM testing help the physician choose how long to cut the muscle. Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.

Primary Outcome

Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years.

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2026-06-01
Est. Completion 2030-03-01
Northwestern University

1,209 total trials

What NCT07293689 shows while recruiting

NCT07293689 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT07293689 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07293689 about?

NCT07293689 is a clinical study titled "PREcision MEDicine In Achalasia (PREMEDIA) - Cohort". The goal of this observational study is to learn about how the doctor decides how long to cut t the esophageal muscle during Per-Oral Endoscopic Myotomy (POEM) in patients with difficulty swallowing due to certain conditions. The main question it aims to answer is: does pre-POEM testing help the phy...

What is the current status of trial NCT07293689?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2026-06-01. Estimated completion is 2030-03-01.

Who is sponsoring clinical trial NCT07293689?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07293689, the US trial registry maintained by the National Library of Medicine. NCT07293689 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.